Understand the source comparison
GHRP-2 vs Other GH Secretagogues: Performance Context
GHRP-2 (Adamax) GHSR-1a agonist 15–30 ~20 min Moderate appetite increase Balanced GH response without excessive hunger; reliable dose-response curve makes it predictable for controlled studies GHRP-6 20–35 Strong appetite increase Higher GH peak but pronounced
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHRP-2 (Adamax)
- GHSR-1a agonist
- 15–30
- ~20 min
- Moderate appetite increase
- Balanced GH response without excessive hunger; reliable dose-response curve makes it predictable for controlled studies
- GHRP-6
- 20–35
- Strong appetite increase
- Higher GH peak but pronounced hunger signaling; less suitable when appetite modulation is a confounding variable
- Ipamorelin
- GHSR-1a agonist (selective)
- 10–18
- ~2 hours
- Minimal
- Most selective GH secretagogue with negligible cortisol or prolactin elevation; lower peak but cleaner hormonal profile
- Hexarelin
- 25–40
- ~70 min
- Moderate
- Highest GH peak but desensitization occurs after 4–6 weeks of daily use; not suitable for long-term studies
- CJC-1295 (DAC)
- GHRH analog
- 8–15 (sustained)
- 6–8 days
- None
- Extends endogenous GH pulsatility rather than creating acute peaks; used in combination protocols
- GHRP-2 sits in the middle of the potency spectrum. More predictable than GHRP-6, more potent than ipamorelin, less prone to desensitization than hexarelin. The moderate ghrelin mimetic effect means researchers should account for potential appetite signaling in behavioral or metabolic studies, but it's far less pronounced than GHRP-6's impact. For dose-response studies or applications where consistent GH peaks matter more than maximal amplitude, GHRP-2 remains the most reliable choice.